BioLife Solutions
BLFS
140 hedge funds and large institutions have $743M invested in BioLife Solutions in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 48 increasing their positions, 54 reducing their positions, and 24 closing their positions.
611% more call options, than puts
Call options by funds: $3.75M | Put options by funds: $528K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
24% more capital invested
Capital invested by funds: $602M → $743M (+$142M)
1.34% more ownership
Funds ownership: 100.19% → 101.53% (+1.3%)
8% less funds holding
Funds holding: 153 → 140 (-13)
11% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 54
42% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$28M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
+$13.2M |
| 3 |
CC
Casdin Capital
New York
|
+$11.8M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$11.1M |
| 5 |
RA
Royce & Associates
New York
|
+$8.02M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$27.8M |
| 2 |
GCM
Geneva Capital Management
Milwaukee,
Wisconsin
|
-$8.3M |
| 3 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$8.26M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$6.06M |
| 5 |
Jennison Associates
New York
|
-$4.65M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RFA
151
Register Financial Advisors
Atlanta,
Georgia
| – | -$71.8K | -5,200 | Closed |
|
152
KBC Group
Brussels,
Belgium
| – | -$25K | -1,779 | Closed |
|
|
PA
153
Parallel Advisors
San Francisco,
California
| – | -$15.1K | -1,096 | Closed |
|
|
BAAM
154
Baker Avenue Asset Management
San Francisco,
California
| – | -$8.2K | -594 | Closed |
|
|
OA
155
Operose Advisors
Milwaukee,
Wisconsin
| – | -$7.15K | -518 | Closed |
|
156
Bessemer Group
Woodbridge,
New Jersey
| – | -$3K | -190 | Closed |
|
|
LFA
157
LGT Financial Advisors
Dallas,
Texas
| – | -$2.38K | -172 | Closed |
|
|
QCG
158
Quadrant Capital Group
Cincinnati,
Ohio
| – | -$1.69K | -122 | Closed |
|
|
SWM
159
Spire Wealth Management
Mclean,
Virginia
| – | -$1.38K | -100 | Closed |
|
|
PWMG
160
Prestige Wealth Management Group
Flemington,
New Jersey
| – | -$1.15K | -83 | Closed |
|
|
GBT
161
Grove Bank & Trust
Miami,
Florida
| – | -$635 | -46 | Closed |
|
|
AF
162
Allworth Financial
Folsom,
California
| – | -$456 | -33 | Closed |
|
|
NRG
163
Nemes Rush Group
Novi,
Michigan
| – | -$83 | -6 | Closed |
|
BLFS Hedge Fund Activity: Q4 2023 in Review
140 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q4 2023, worth a combined $743M — up 24% from $602M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of BLFS and 14 opened new positions — a net loss of 10 holders — while 54 trimmed existing stakes and 48 added.
The largest buyer was Goldman Sachs, adding an estimated $28M. The largest seller was Park West Asset Management, exiting entirely with an estimated $27.8M sold.
- 140 institutional investors held BioLife Solutions (BLFS) as of Q4 2023, down from 153 in Q3 2023.
- Funds reported $743M of BioLife Solutions stock for Q4 2023, up 24% quarter-over-quarter.
- 14 funds opened new BioLife Solutions positions in Q4 2023 and 24 closed out, a net change of -10 holders.
- The largest BioLife Solutions buyer in Q4 2023 was Goldman Sachs, an estimated $28M added.
- The largest BioLife Solutions seller in Q4 2023 was Park West Asset Management, an estimated $27.8M sold.
Based on aggregated 13F filings for Q4 2023.